Product
AstroStem-V
1 clinical trial
1 indication
Indication
COVID-19 pneumoniaClinical trial
A Phase I/Ⅱa Trial to Explore the Safety and Efficacy of Allogenic Adipose Tissue-derived Mesenchymal Stem Cell (AstroStem-V) Therapy in Patients With COVID-19 PneumoniaStatus: Recruiting, Estimated PCD: 2023-11-01